Contact: +91 99725 24322 |
Menu
Menu
Quick summary: Learn how pharma importers in France can prepare for PPWR compliance. Understand importer responsibilities, pharmaceutical packaging documentation, supplier verification, technical documentation, packaging conformity, and packaging data management before the August 2026 compliance milestone.
France, home to Europe’s largest pharmaceutical market and a major distribution hub for medicines entering the European Union, is a critical gateway for imported pharmaceutical products. From active pharmaceutical ingredients, generics, biologics, and vaccines to over-the-counter medicines, medical devices packaging, and hospital supplies, pharma importers play a critical role in supplying the French and wider European market.
With the introduction of the EU Packaging and Packaging Waste Regulation (PPWR), pharma importers must now ensure that the packaging accompanying imported products complies with applicable EU packaging requirements before those products are placed on the market.
While overseas manufacturers are responsible for producing packaged pharmaceutical products, importers are responsible for ensuring that imported packaging is supported by the necessary technical documentation, supplier information, and compliance evidence required under PPWR.
Unlike the previous Packaging and Packaging Waste Directive, PPWR (Regulation (EU) 2025/40) applies directly across all EU Member States. It entered into force on 11 February 2025 and its core provisions apply from 12 August 2026, creating harmonized obligations for manufacturers, importers, distributors, and other economic operators involved in placing packaged products on the EU market. In France, PPWR sits alongside the existing French Environmental Code, including registration in the Citeo administered by the Citeo and participation in a Citeo compliance system for licensing.
For pharma importers managing complex global supplier networks, strict quality requirements, and sensitive cold-chain logistics, compliance extends far beyond customs documentation. It requires structured packaging data, supplier collaboration, technical documentation, conformity verification, and scalable compliance processes that can support thousands of imported SKUs.
Organizations that begin preparing now will be better positioned to meet upcoming implementation milestones, reduce supply chain risks, respond to wholesaler and pharmacy requirements, and demonstrate compliance during regulatory inspections.
If your organization imports packaged pharmaceutical products into France, PPWR introduces new responsibilities across the packaging lifecycle.
Key priorities include:
Rather than treating PPWR as a one-time compliance exercise, pharma importers should establish scalable packaging governance processes that strengthen supplier collaboration and support long-term regulatory compliance — alongside existing Citeo registration and Citeo compliance system obligations under French Environmental Code.
The Packaging and Packaging Waste Regulation (PPWR) establishes a harmonized legal framework governing packaging placed on the European Union market.
Its objectives are to:
Unlike the previous Packaging and Packaging Waste Directive, which required implementation through national legislation, PPWR applies directly across all EU Member States. This creates a consistent regulatory framework while assigning clear responsibilities to manufacturers, importers, distributors, brand owners, and other economic operators.
The regulation covers packaging throughout its lifecycle, including:
For pharma importers, compliance goes beyond sourcing packaged products. Businesses should verify that imported packaging satisfies applicable PPWR requirements through supplier documentation, conformity evidence, and structured packaging data management before products are placed on the EU market — while continuing to meet existing pharmaceutical packaging and labelling obligations under French and EU medicines law.
France imports significant volumes of packaged pharmaceutical products every year, both to meet domestic patient and hospital demand and to support its role as a major re-export and distribution hub for the wider European market.
Common imported pharma categories include:
These products are packaged using a wide variety of materials, including:
Pharmaceutical packaging presents unique compliance challenges because it must protect product sterility and stability, preserve shelf life, ensure patient safety, support serialization and anti-tampering requirements, and withstand cold-chain logistics while also meeting sustainability requirements under PPWR.
Importers cannot assume that overseas manufacturers have already addressed every packaging compliance requirement.
Before placing products on the EU market, pharma importers should verify that appropriate technical documentation and supporting evidence are available for every packaging component.
This requires close collaboration with:
Without structured compliance processes, organizations may face:
At the same time, wholesalers, health authorities, and regulators are demanding greater transparency around packaging sustainability, making PPWR compliance both a regulatory requirement and a strategic business advantage.
Understanding your role in the packaging value chain is the first step toward building an effective compliance strategy.
Read our Complete Guide to PPWR Roles & Responsibilities.
Although several PPWR obligations including packaging minimization, recycled-content targets, and reuse requirements will be introduced progressively over the coming years, 12 August 2026 marks the first major compliance milestone.
By this date, pharma importers placing packaged products on the EU market should be prepared to demonstrate compliance with the applicable provisions of the regulation.
Rather than waiting until implementation deadlines approach, organizations should begin building the supplier engagement processes, packaging governance framework, technical documentation repository, and packaging data management capabilities needed to support long-term compliance.
Pharma importers operate within one of the most tightly regulated packaging ecosystems. A single imported product may contain primary packaging (blister, vial, syringe, or bottle), secondary cartons, patient information leaflets, tamper-evident seals, cold-chain packaging, and transport packaging — often sourced from multiple suppliers across different countries.
Under PPWR, importers should establish processes to verify that packaging complies with applicable regulatory requirements before products are placed on the EU market.
Below are six priority areas every pharma importer should focus on.
Pharma importers should not assume that overseas manufacturers have already addressed every PPWR requirement.
Instead, they should establish a packaging verification process covering:
Verifying compliance early helps prevent product delays, supplier disputes, and costly corrective actions.
Technical documentation is likely to become one of the most requested compliance assets under PPWR.
For imported pharmaceutical products, documentation may originate from:
Rather than storing documents across emails and shared drives, pharma importers should maintain a centralized repository containing:
A structured documentation system improves audit readiness and simplifies wholesaler and regulatory requests.
Pharmaceutical packaging frequently changes because of:
Without continuous supplier collaboration, documentation quickly becomes outdated.
Importers should establish standardized workflows for:
Digital collaboration reduces manual follow-ups while improving data quality and supplier accountability.
Many pharma importers manage packaging information across multiple systems.
Typical sources include:
This fragmented approach makes it difficult to demonstrate compliance across large product portfolios.
A centralized packaging data management strategy should include:
Having one trusted source of packaging information improves consistency and supports future reporting requirements, including annual Citeo reporting and Citeo compliance system declarations under French Environmental Code.
Large wholesalers, national competent authorities, and market surveillance authorities increasingly expect importers to demonstrate packaging compliance through documented evidence.
Pharma importers should be prepared to provide:
Organizations with structured documentation processes can respond quickly, reducing business disruption during inspections or wholesaler audits.
PPWR is only one element of Europe’s evolving sustainability regulatory landscape.
Pharma importers may also need to prepare for:
Instead of creating separate compliance processes for each regulation, organizations should establish a shared digital foundation for supplier information, packaging data, technical documentation, and compliance evidence.
This reduces duplication while improving operational efficiency across multiple regulatory initiatives — while continuing to maintain existing serialization and anti-falsification safeguards under EU medicines law alongside new packaging sustainability requirements.
A French importer sources generic tablets packaged in PVC/Alu blister packs and folding cartons.
Before placing the product on the EU market, the importer should obtain packaging specifications, material composition, supplier declarations, and supporting technical documentation for the blister and carton packaging.
Temperature-sensitive biologics are shipped in glass vials with cold-chain insulated secondary packaging sourced from different suppliers.
The importer should maintain documentation for every packaging component and ensure packaging changes are reflected in technical records.
An overseas manufacturer changes the bottle material to reduce cost without notifying the importer.
Without change management and version control, outdated technical documentation may no longer reflect the packaging placed on the EU market.
A French pharmaceutical wholesaler requests evidence that imported packaging complies with PPWR requirements before distributing a new product.
Importers with centralized packaging documentation can respond quickly, while manual processes often result in delays and repeated supplier requests.
As PPWR implementation progresses, pharma importers are likely to encounter challenges such as:
Addressing these challenges requires more than collecting certificates. It requires structured packaging governance, supplier collaboration, and centralized packaging information.
Meeting PPWR requirements starts with accurate packaging data, robust technical documentation, and effective supplier collaboration.
Learn how to prepare your organization for packaging conformity assessments, documentation requirements, recyclability obligations, and ongoing compliance.
Read our Complete Guide to PPWR Technical Requirements.
For pharma importers, PPWR compliance extends beyond verifying packaging specifications. It requires an organized approach to supplier collaboration, packaging governance, technical documentation, and data management across global supply chains.
As pharmaceutical packaging becomes more complex and regulatory expectations continue to evolve, businesses that rely on manual documentation and fragmented systems may struggle to maintain compliance. Establishing a structured compliance framework today will help organizations reduce operational risk and improve long-term supply chain resilience.
A successful PPWR program should involve procurement, quality assurance, packaging, regulatory affairs, sustainability, logistics, and supplier management teams.
The following five pillars provide a practical roadmap for implementation.
Pharma importers often source products from multiple manufacturers, each using different packaging suppliers and documentation formats.
Instead of maintaining packaging information across spreadsheets, shared drives, and emails, organizations should centralize information such as:
A centralized repository improves consistency while reducing the time required to respond to wholesaler or regulatory requests.
Pharma importers depend heavily on suppliers for packaging compliance information.
A structured supplier collaboration process should include:
Digitizing these interactions reduces manual communication while improving data accuracy and supplier accountability.
Packaging documentation should evolve alongside the product.
Whenever packaging materials, suppliers, dimensions, or designs change, documentation should be reviewed and updated.
Organizations should maintain version-controlled records for:
This ensures that documentation accurately reflects the packaging currently placed on the EU market.
Pharmaceutical packaging changes frequently due to:
Without formal governance, outdated documentation can quickly create compliance risks.
Importers should establish internal approval workflows to verify packaging changes before products enter the European market.
PPWR compliance should not be treated as a one-time project completed before a deadline.
Instead, organizations should continuously maintain:
This enables faster responses to inspections, wholesaler requests, and regulatory inquiries while reducing business disruption.
PPWR introduces requirements that go far beyond packaging design. From technical documentation and conformity assessments to recyclability, packaging minimization, and economic operator obligations, understanding the regulation is essential for building a compliant packaging strategy.
Read our Complete Guide to PPWR Requirements.
Managing packaging compliance across multiple countries, suppliers, packaging formats, and product categories can quickly become difficult using spreadsheets and email.
TraceX PPWR Solutions provides a centralized digital platform that helps pharma importers manage packaging compliance from supplier onboarding through ongoing regulatory readiness.
Maintain packaging specifications, material composition, supplier information, recycled-content data, and compliance records in one secure platform.
Collect packaging information directly from suppliers using standardized digital workflows, reducing manual follow-ups and improving response times.
Store, organize, and maintain version-controlled technical documentation, laboratory reports, certificates, declarations, and supporting compliance evidence.
Create visibility across packaging suppliers, manufacturing sites, packaging components, and imported pharmaceutical products to support stronger compliance and governance.
Build the documentation, supplier engagement processes, and packaging governance needed to support packaging conformity, technical documentation requirements, and future regulatory obligations — alongside existing Citeo registration and French Environmental Code reporting.
Whether importing pharmaceutical products from India, China, the United States, Switzerland, or elsewhere, TraceX helps standardize packaging compliance across your global supplier network.
Schedule a PPWR Readiness Assessment to evaluate your current packaging compliance processes, identify gaps, and build a scalable roadmap for meeting PPWR requirements with confidence.
For pharma importers in France, PPWR is more than a packaging regulation — it is a catalyst for improving packaging governance, supplier collaboration, and operational transparency.
Organizations that continue relying on fragmented documentation, manual communication, and disconnected systems may find it increasingly difficult to keep pace with evolving regulatory and wholesaler expectations.
By investing in centralized packaging data, structured supplier engagement, and digital compliance processes, pharma importers can reduce compliance risks, improve operational efficiency, and build a future-ready packaging compliance program that supports long-term business growth — while continuing to meet their existing Citeo registration and Citeo compliance system obligations under French Environmental Code.
Yes. Pharma importers placing packaged pharmaceutical products on the EU market have responsibilities under PPWR and should verify that imported packaging complies with applicable regulatory requirements before products are made available in the EU.
Depending on the packaging and applicable requirements, importers should collect documentation such as:
Manufacturers have obligations relating to the packaging they produce, but pharma importers should verify that appropriate compliance documentation is available before placing packaged products on the EU market. Importers should not rely solely on supplier assurances without maintaining supporting records.
Citeo is France’s national packaging register, run by the Citeo under the French Environmental Code, and importers must register there and participate in a Citeo compliance system for packaging placed on the French market. PPWR does not replace this system, but it adds EU-wide design, recyclability, labelling, and documentation requirements that importers must meet alongside their existing French registration and licensing obligations.
Digital platforms help pharma importers centralize packaging data, automate supplier collaboration, manage technical documentation, maintain version-controlled records, and improve audit readiness across the packaging lifecycle.